Aytu Biopharma, Inc: Form 8-K, filed Nov 17, 2023
Filed with the SEC on Nov 17, 2023 and accepted by EDGAR at Nov 17, 2023, 16:10 ET.
Items reported
- Item 1.01 Entry into a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001558370-23-019194. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.